These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
23. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis. Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551 [TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA Xu Y; Wang J; Wang J Onco Targets Ther; 2018; 11():5035-5043. PubMed ID: 30174441 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway. Bi CL; Zhang YQ; Li B; Guo M; Fu YL J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929 [TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer. Zou X; Guo ZH; Li Q; Wang PS Cancer Manag Res; 2020; 12():199-207. PubMed ID: 32021436 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p. Li Y; Qin J; He Z; Cui G; Zhang K; Wu B Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227 [TBL] [Abstract][Full Text] [Related]
28. MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2. Huang Y; Zhang H; Wang L; Liu C; Guo M; Tan H; Liu Z Cancer Cell Int; 2021 Sep; 21(1):494. PubMed ID: 34530821 [TBL] [Abstract][Full Text] [Related]
29. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221 [TBL] [Abstract][Full Text] [Related]
30. Ultrasound-Targeted Microbubble Destruction-Mediated miR-206 Overexpression Promotes Apoptosis and Inhibits Metastasis of Hepatocellular Carcinoma Cells Via Targeting PPIB. Wu H; Xie D; Yang Y; Yang Q; Shi X; Yang R Technol Cancer Res Treat; 2020; 19():1533033820959355. PubMed ID: 33111654 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition. Wei ZL; Gao AB; Wang Q; Lou XE; Zhao J; Lu QJ Onco Targets Ther; 2019; 12():2323-2333. PubMed ID: 30992669 [TBL] [Abstract][Full Text] [Related]
32. Circ_0058124 Aggravates the Progression of Papillary Thyroid Carcinoma by Activating LMO4 Expression via Targeting miR-370-3p. Liu L; Yan C; Tao S; Wang H Cancer Manag Res; 2020; 12():9459-9470. PubMed ID: 33061633 [TBL] [Abstract][Full Text] [Related]
33. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
34. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
35. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling. Zheng H; Fu Q; Ma K; Shi S; Fu Y Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758 [TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid Carcinoma. Zhang F; Cai Y; Diao B; Song D; Miao R; Zhang B; Hu Y; Zeng H; Hu X Cancer Manag Res; 2020; 12():10311-10319. PubMed ID: 33116886 [TBL] [Abstract][Full Text] [Related]
37. LncRNA Li W; Ge J; Xie J; Yang J; Chen J; He T Cancer Biother Radiopharm; 2021 Dec; 36(10):850-862. PubMed ID: 32589479 [No Abstract] [Full Text] [Related]
38. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma. Zang CS; Huang HT; Qiu J; Sun J; Ge RF; Jiang LW Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4890-4900. PubMed ID: 32432752 [TBL] [Abstract][Full Text] [Related]
39. Knockdown of circPVT1 inhibits progression of papillary thyroid carcinoma by sponging miR-126. Tao L; Yang L; Tian P; Guo X; Chen Y RSC Adv; 2019 Apr; 9(23):13316-13324. PubMed ID: 35520785 [No Abstract] [Full Text] [Related]
40. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer. Ji L; Fan X; Zhou F; Gu J; Deng X J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]